Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Eur J Pharm Biopharm. 2015 Feb 26;92:74–82. doi: 10.1016/j.ejpb.2015.02.006

Table I.

Ocular tissue hesperetin (HT) concentrations (μg/gm of tissue) obtained from 10 %w/w & 20 %w/w films 1, 3 or 6 hours post topical application. All experiments were performed in triplicate.

Formulation Dose (mg) Duration (h) μg/gm of Tissue
AH VH RC IC Cornea Sclera
10% w/w HT film 0.8 mg 1h 4.2 ± 0.4 0.05 ± 0.03 7.8 ± 0.2 37.6 ± 6.2 14.1 ± 0.2 5.1 ± 0.9
10% w/w HT film 0.8 mg 3h 1.2 ± 0.1 0.06 ± 0.02 1.8 ± 0.5 4.2 ± 1.1 8.5 ± 0.9 14.6 ± 8.8
20% w/w HT film 1.6 mg 1h 7.2 ± 3.6 1.4 ± 0.5 23.5 ± 6.9 44.9 ± 19.7 33.5 ± 5.4 53.2 ± 5.2
20% w/w HT film 1.6 mg 3h 3.4 ± 0.9 0.16 ± 0.07 3.3 ± 0.4 7.7 ± 0.8 14.1 ± 1.1 39.8 ± 16.1
20% w/w HT film 1.6 mg 6h ND 0.03 ± 0.02 0.38 ± 0.02 1.5 ± 0.1 ND 6.1 ± 1.6

AH - Aqueous Humor; VH - Vitreous Humor; RC - Retina-Choroid & IC - Iris Ciliary bodies.